News + Filings Transactions
|
MARTIN JOHN C
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 03/03/2021 | Sarepta Therapeutics, Inc. | SRPT | Grant | Common Stock | 2.7k | $0.00 | $0 | | 03/03/2021 |
| 03/03/2021 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock Option (right to buy) | 5.5k | $87.11 | $480.7k | | 03/03/2021 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 914.3k | $0.00 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 757k | $0.00 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Common Stock | 205.3k | $16.15 | $3.3M | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Purchase | Common Stock | 75.8k | $19.00 | $1.4M | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series Seed Preferred Stock | 866.7k | $0.00 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Series A Preferred Stock | 717.5k | $0.00 | $0 | See footnote | 10/14/2020 |
| 10/14/2020 | Kronos Bio, Inc. | KRON | Conversion | Convertible Promissory Note | 0 | $16.15 | $0 | See footnote | 10/14/2020 |
| 02/28/2020 | Sarepta Therapeutics, Inc. | SRPT | Grant | Common Stock | 3.1k | $0.00 | $0 | | 02/28/2020 |
| 02/28/2020 | Sarepta Therapeutics, Inc. | SRPT | Grant | Common Stock | 2.1k | $0.00 | $0 | | 02/28/2020 |
| 02/28/2020 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock option (right to buy) | 5.5k | $114.47 | $632.8k | | 02/28/2020 |
| 02/28/2020 | Sarepta Therapeutics, Inc. | SRPT | Grant | Stock option (right to buy) | 3.7k | $114.47 | $421.8k | | 02/28/2020 |
| 02/06/2019 | GILEAD SCIENCES, INC. | GILD | Grant | Common Stock | 15.5k | $0.00 | $0 | | 02/06/2019 |
| 02/06/2019 | GILEAD SCIENCES, INC. | GILD | Payment of Exercise | Common Stock | 13.8k | $68.75 | $947.9k | | 02/06/2019 |
| 02/06/2019 | GILEAD SCIENCES, INC. | GILD | Grant | Common Stock | 7.7k | $0.00 | $0 | | 02/06/2019 |
| 12/03/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 35.8k | $70.90 | $2.5M | | 11/29/2018 |
| 12/03/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 14k | $71.95 | $1M | | 11/29/2018 |
| 12/03/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 200 | $72.67 | $14.5k | | 11/29/2018 |
| 12/03/2018 | GILEAD SCIENCES, INC. | GILD | Exercise | Non-qualified Stock Option (Right to Buy) | 50k | $23.60 | $1.2M | | 11/29/2018 |
| 11/29/2018 | GILEAD SCIENCES, INC. | GILD | Gift | Common Stock | 140k | $0.00 | $0 | | 11/29/2018 |
| 11/01/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 8k | $68.61 | $548.9k | | 11/01/2018 |
| 11/01/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 28.4k | $69.53 | $2M | | 11/01/2018 |
| 11/01/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 13.6k | $70.15 | $952.6k | | 11/01/2018 |
| 11/01/2018 | GILEAD SCIENCES, INC. | GILD | Exercise | Non-qualified Stock Option (Right to Buy) | 50k | $23.60 | $1.2M | | 11/01/2018 |
| 09/04/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 47.4k | $74.11 | $3.5M | | 09/04/2018 |
| 09/04/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 2.6k | $75.00 | $196.8k | | 09/04/2018 |
| 09/04/2018 | GILEAD SCIENCES, INC. | GILD | Exercise | Non-qualified Stock Option (Right to Buy) | 50k | $23.60 | $1.2M | | 09/04/2018 |
| 08/01/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 50k | $77.85 | $3.9M | | 08/01/2018 |
| 08/01/2018 | GILEAD SCIENCES, INC. | GILD | Exercise | Non-qualified Stock Option (Right to Buy) | 50k | $23.60 | $1.2M | | 08/01/2018 |
| 07/02/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 49.7k | $70.80 | $3.5M | | 07/02/2018 |
| 07/02/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 300 | $71.36 | $21.4k | | 07/02/2018 |
| 07/02/2018 | GILEAD SCIENCES, INC. | GILD | Exercise | Non-qualified Stock Option (Right to Buy) | 50k | $23.60 | $1.2M | | 07/02/2018 |
| 06/01/2018 | GILEAD SCIENCES, INC. | GILD | Sale | Common Stock | 50k | $68.13 | $3.4M | | 06/01/2018 |
| 06/01/2018 | GILEAD SCIENCES, INC. | GILD | Exercise | Non-qualified Stock Option (Right to Buy) | 50k | $23.60 | $1.2M | | 06/01/2018 |
|
|